Stratified medicine aims to match patients with their best management options and thereby improve outcomes. Most of our cancer clinical trials now incorporate stratified research questions as part of their design.
There is a need to evaluate simpler, less toxic cost-effective therapies. Much of the clinical trials activity in our unit is dedicated to this area of research.
Systematic reviews are key tools for identifying the best therapies for patients. We aim to speed up and improve the design of the next generation of prostate cancer trials.
Can regular aspirin use after standard therapy prevent disease recurrence and prolong survival in participants with common, non-metastatic solid tumours?
A trial that aims to find the best treatment for people with advanced prostate cancer.
Aiming to find out whether taking one drug (durvalumab) or a combination of two drugs (durvalumab and tremelimumab) can prevent or delay kidney cancer coming back.
Identifying the most effective treatments for patients with different genetic sub-types of colorectal (bowel) cancer.
Speeding up the evaluation of therapies for metastatic hormone-sensitive prostate cancer.
All Cancer Studies
Our unit have been conducting trials in cancer for over 20 years.
View list of Cancer studies.